Hummingbird Diagnostics GmbH: Hummingbird Diagnostics Publishes Study of miRisk as a Predictor of Immunotherapy Efficacy in Advanced-Stage NSCLC : vimarsana.com

Proprietary microRNA signature (miRisk) may support immunotherapy treatment decisions as a blood-based complementary diagnostic Results published in Journal of Thoracic Oncology Clinical and Research

Related Keywords

Grosshansdorf , Schleswig Holstein , Germany , Timothy Rajakumar , Petros Christopoulos , Bruno Steinkraus , Karen Sharma , Kostenloser Wertpapierhandel , Martin Reck , Thoraxklinik At Heidelberg University Hospital , Thoracic Oncology Clinical , Diagnostics Gmbh , Research Reports , Precision Oncology , Medical Director , Hummingbird Diagnostics , Professor Petros Christopoulos , Heidelberg University Hospital , Professor Martin Reck , Chief Scientific Officer , Dougall Advisors , Hummingbird , Iagnostics , Mbh , Ublishes , Tudy , Irisk , Redictor , Mmunotherapy , Fficacy , Dvanced , Tage , Sclc ,